French drug major Sanofi (SNY) and Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the U.S. Food and Drug Administration ...
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity M ...
Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback